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Abstract
Background: Since technique modifications of laparoscopic donor nephrectomy, e.g. retroperitoneoscopic donor
nephrectomy or hand-assistance, have not shown significant benefit regarding safety or improvement of recovery,
further research should focus on improving postoperative recovery. The use of low pressure pneumoperitoneum
has shown to significantly reduce postoperative pain after laparoscopy. To facilitate the use of low pressure
pneumoperitoneum, deep neuromuscular block will be used.
Methods/Design: This trial is a phase IV, single center, double-blind, randomized controlled clinical trial in which 64
patients will be randomized to: low pressure pneumoperitoneum (6 mmHg) and deep neuromuscular block or normal
pressure pneumoperitoneum (12 mmHg) and deep neuromuscular block. Deep neuromuscular block is defined as
post tetanic count < 5. Primary outcome measurement will be Quality of Recovery-40 questionnaire (overall score)
on day 1.
Discussion: This study is the first randomized study to assess the combination of low pressure pneumoperitoneum in
combination with deep neuromuscular block from a patients’ perspective. The study findings may also be applicable
for other laparoscopic procedures.
Trial registration: The trial was registered at trials.gov (NCT02146417) in July 2014.
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Background
Since the introduction of laparoscopic donor nephrec-
tomy in 1995 by Ratner et al. [1], several trials have been
performed comparing laparoscopic versus open donor
nephrectomy. A Cochrane systematic review has shown
that laparoscopic donor nephrectomy is associated with
less post-operative pain, better quality of life and shorter
hospital stay for the donor [2]. Therefore, in most coun-
tries, laparoscopic donor nephrectomy is nowadays the
procedure of first choice.
So far, modifications of the technique of laparoscopic
donor nephrectomy, i.e. hand-assisted and/or retroperito-
neoscopic approaches, did not show a significant benefit
with regard to safety as reflected by the conversion to
open donor nephrectomy and postoperative complications
[3–6]. Therefore, further research should focus on early
postoperative recovery. Postoperative recovery is largely
determined by the consequences of postoperative pain
and its concomitant use of opioids. Measures to reduce
postoperative pain will also reduce opioid-associated side-
effects, including postoperative nausea and vomitus.
A recent pilot study performed by our group has
shown that low pressure pneumoperitoneum (7 mmHg)
was feasible and significantly reduced postoperative pain
scores during the first 72 hours after surgery [7]. Others
have shown that low pressure pneumoperitoneum in
other laparoscopic procedures is associated with a re-
duction of post-operative pain and analgesic consump-
tion [8–10]. However, low pressure pneumoperitoneum
was also associated with longer operation time, probably
due to less optimal perioperative visibility. To facilitate
low pressure pneumoperitoneum deep neuromuscular
block can be used; Martini et al. have shown that peri-
operative visibility can be improved by deep neuromus-
cular block in normal pressure pneumoperitoneum [11].
Therefore, deep neuromuscular block might become a pre-
requisite for the use of low pressure pneumoperitoneum.
However, the extended effects of deep neuromuscu-
lar block may lead to postoperative complications, in-
cluding airway obstruction, hypoxia, pneumonia and
residual muscle paralysis, necessitating prolonged stay in
the post-anaesthesia care unit [12, 13]. To prevent this,
sugammadex, a modified γ-cyclodextrine that binds to
rocuronium in plasma and tissues, will be administrated.
Our hypothesis is that, for patients undergoing laparo-
scopic donor nephrectomy, low pressure pneumoperitoneum
leads to improved postoperative recovery as compared to
patients with standard pressure pneumoperitoneum.
Methods/Design
The protocol of the study was approved by the local ethics
committee (NL48056.091.14, Central Committee on Re-
search involving Human Subjects, Arnhem – Nijmegen)
and registered at clinicaltrials.gov (NCT02146417). This
single center, double-blind, randomized controlled trial
will be performed at the Radboud University Medical
Center. Inclusion will be performed by the research phys-
ician after written informed consent.
Study population
A total of 64 patients will be randomized based on a
computer-generated list, using sealed, opaque envelopes
(1:1) to either low pressure pneumoperitoneum (6 mmHg)
and deep neuromuscular block or normal pressure pneu-
moperitoneum (12 mmHg) and deep neuromuscular
block. Stratification for gender and site of donor nephrec-
tomy will be used. As the range in age of live kidney
donors in our center is relatively small (between 40 and
60 years), we will not stratify for age. All adult individuals
who were considered to be suitable for live kidney
donation after multidisciplinary discussion (nephrologist,
vascular surgeon and urologist) are eligible for this study.
Inclusion criteria
 Informed consent obtained
 Age over 18 years
Exclusion criteria
 Insufficient control of the Dutch language to read
the patient information and to fill out the
questionnaires
 Chronic use of analgesics or psychotropic drugs
 Use of nonsteroidal anti-inflammatory drugs < 5
days before surgery
 Known or suspect allergy to rocuronium or
sugammadex
 Significant liver or renal dysfunction
 Neuromuscular disease
 Pregnant or breastfeeding
 Indication for rapid sequence induction
Liver dysfunction is defined as alanine aminotransfer-
ase (ALAT) and/or aspartate aminotransferase (ASAT)
more than twice the upper limit. Renal dysfunction is
defined as serum creatinine twice the normal level
(upper limit of 201 μmol/l) and/or glomerular filtration
rate < 60 ml/minute. Both renal and liver dysfunction
are extremely rare in live kidney donors.
Study protocol
Before arrival at the operating room, all monitors and
screens displaying information regarding the intra-
abdominal pressure will be covered for the anesthesiologist,
surgeons, research physician and scrub nurses. An inde-
pendent scrub nurse from an adjacent operating room con-
sults the randomization tool and will be informed about
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the allocation of the treatment. Subsequently, the inde-
pendent scrub nurse installs the pneumoperitoneum insuf-
flation pressure at 6 mmHg or 12 mmHg.
All laparoscopic procedures will be performed by two
teams consisting of a fixed combination of one vascular
surgeon and one urologist. The surgical rating score will
be scored by the primary surgeon. Each surgeon has per-
formed more than 30 laparoscopic donor nephrectomies.
Anaesthesia will be induced with propofol 1–3 mg/kg
and sufentanyl 0.2–0.5 μg/kg. Deep neuromuscular block
will be induced by rocuronium bolus 1.0 mg/kg. To cali-
brate the train-of-four (TOF)-Watch (TOF-Watch SX,
MSD, Haarlem, the Netherlands), first a tetanic ulnar
nerve stimulus (50 Hz for 5 seconds) will be adminis-
tered. Thereafter, the TOF-Watch will be calibrated,
followed by 3 measurements to ensure that the TOF ra-
tio differs by less than 5 %. If the TOF ratio differs > 5 %
the TOF-Watch will be recalibrated. Anesthesia will be
maintained by sufentanyl 0.05–0.5 μg/kg/h and sevoflur-
ane. Deep neuromuscular block will be maintained by a
continuous infusion of rocuronium (0.3 mg/kg/h). In case
of persistent post-tetanic count (PTC) values of 0, continu-
ous infusion will be paused; when PTC increases to > 5,
the pump speed will be increased and/or an extra bolus of
rocuronium will be given.
After open introduction of the first trocar, the surgeon
assesses surgical rating scale (SRS) according to Martini
et al. (see Table 1) [11]. The SRS score will only be based
on actual intra-abdominal conditions, e.g. in case of
problems with the laparoscopic camera, this will be ex-
cluded as cause of poor visibility. If SRS is ≥ 3 the pro-
cedure will be continued. If the SRS is ≤ 2 the
pneumoperitoneum pressure will be increased stepwise
(by the independent scrub nurse), according to Fig. 1.
Before each step (introduction of trocars, dissection of
the kidney and kidney extraction), surgical conditions
are assessed by the surgeon. During the dissection phase
surgical conditions will be assessed every 15 minutes. In
case increasing the intra-abdominal pressure to normal
(12 mmHg) does not improve the SRS to ≥ 3, the sur-
geon decides to take further action, e.g. conversion to
hand-assisted or open donor nephrectomy, but will not
be informed about the initial pressure. The (independ-
ent) research physician will register intra-operative pa-
rameters (e.g. blood loss, first warm ischemia time,
conversion to open or hand-assisted donor nephrectomy
and intra-operative complications).
Pain management is achieved by patient-controlled anal-
gesia with Dipidolor (piritramide) (bolus 1 mg, lock-out 6
minutes) and acetaminophen (total 4000 mg daily). When
no complications occur and pain management is satisfac-
tory: on day 2, patient-controlled analgesia will be stopped
and replaced by oral analgesics. On day 0, post-operative
pain will be assessed every 4 hours; thereafter, pain will be
assessed every 8 hours. On day 0, patients are offered a
liquid meal; thereafter, patients are encouraged to eat regu-
lar meals. The research physician will assess all post-
operative pain scores and perform daily evaluation with re-
gard to the use of analgesics and anti-emetics and urine
output. In case of nausea and/or vomiting, ondansetron
(4 mg intravenous, maximum 12 mg) is given; second
choice is metoclopramide (10 mg intravenous, maximum
30 mg). Since the spouse or child of the patient is
frequently the recipient of the donor, patients are often
admitted for longer than strictly medically necessary.
Therefore, the following discharge criteria will be evaluated
daily: 1) satisfactory pain management with oral analgesia,
2) passage of flatulence and feces, 3) ability to walk over the
ward, 4) ability to wash and change clothes independently.
Outcome measures
Primary outcome measure is total score of the Quality
of Recovery-40 (QoR-40) questionnaire on post-
operative day 1. The QoR-40 questionnaire provides a
global score and sub-score in 5 dimensions: patient sup-
port, comfort, emotions, physical independence and
pain. An improvement in the quality of recovery is dir-
ectly related to patient satisfaction [14]. Also, there is a
Table 1 Assessment of surgical space condition, according to Martini et al. [11]
Scale Description
1 Extremely poor
conditions
The surgeon is unable to work because of coughing or because of the inability to obtain a visible laparoscopic field
because of inadequate muscle relaxation. Additional neuromuscular blocking agents must be given
2 Poor conditions There is a visible laparoscopic field, but the surgeon is severely hampered by inadequate muscle relaxation with
continuous muscle contractions, movements, or both with the hazard of tissue damage. Additional neuromuscular
blocking agents must be given
3 Acceptable
conditions
There is a wide visible laparoscopic field but muscle contractions, movements, or both occur regularly causing some
interference with the surgeon’s work. There is the need for additional neuromuscular blocking agents to prevent
deterioration
4 Good conditions There is a wide laparoscopic field with sporadic muscle contractions, movements, or both. There is no immediate need
for additional neuromuscular blocking agents unless there is the fear of deterioration
5 Optimal conditions There is a wide visible laparoscopic working field without any movement or contractions. There is no need for
additional neuromuscular blocking agents
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Fig. 1 Flow chart
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relationship between quality of recovery in the days and
weeks after surgery, with quality of life up to 3 years
after cardiac surgery [15]. In accordance with the litera-
ture, we expect the greatest difference of low versus
standard pressure pneumoperitoneum regarding the
QoR-40 at post-operative day 1 [16–18].
Secondary outcome measures include:
 Intra-operative parameters (e.g. intra-operative
complications, conversion to open or hand-assisted
donor nephrectomy, duration of pneumoperitoneum,
estimated blood loss, first warm ischemia time)
 Post-operative complications
 Use of anti-emetics and analgesics
 Post-operative pain
 Nausea and vomiting
 Discharge criteria
 Return to work
 Serum creatinine
The QoR-40 questionnaire is assessed on days −1, 1, 2
and 3 and week 1. Components of pain are assessed on
days −1, 0, 1, 2 and 3, week 6 and month 3. On the day
of surgery, components of pain are measured 1 to 2
hours after surgery. Return to work questionnaire is
measured at weeks 4 and 6 and month 3. Medication
use is, during hospital admission, evaluated daily. Serum
creatinine is measured on days −1 and 2 and after 6
weeks. Other laboratory investigations are only per-
formed when indicated by the attending physician. For a
complete overview of the time schedule see Table 2.
Ethics, informed consent
The Central Committee on Research involving Human
Subjects, Arnhem-Nijmegen, approved the protocol.
Oral and written informed consent will be obtained from
the patient before inclusion.
Adverse events and reactions
Our pilot study has shown that the use of low pressure
pneumoperitoneum in laparoscopic donor nephrectomy
is feasible and can decrease post-operative pain [7]. A
Cochrane review comparing low pressure pneumoperi-
toneum in laparoscopic cholecystectomy [8] showed no
difference in mortality, morbidity or conversion to open
cholecystectomy between both groups.
Martini et al. have shown that deep neuromuscular block
increases surgical visibility during laparoscopy with normal
intra-abdominal pressure [11]. Deep neuromuscular block
can be achieved with rocuronium. Rocuronium can safely
be administrated to patients with cardiac and/or pulmonary
comorbidity. To monitor neuromuscular blockade, TOF
measurements will be assessed every 10 minutes during the
procedure. To avoid residual paralysis, necessitating pro-
longed stay on the post-anesthesia care unit, sugammadex
will be administered. Patients will only be extubated when
TOF is > 90 %. Furthermore, patients will stay at the post-
anesthesia care unit for 2 hours, to ensure adequate neuro-
muscular function.
Sample size calculation
A sample size of 32 patients per group is needed to pro-
vide 80 % power to detect a 10-point difference in the
Table 2 Time schedule
D −1 D 0 D 1 D 2 D 3 W 1 W 4 W 6
Questionnaires
QoR-40 X X X X X
Return to work X X
Medication use
Use of opioids X X X X X X
Use of other analgesics X X X X X X
Evaluation of anti-emetic use X X X X X X
Clinical parameters
Components of pain X X X X X X
Nausea score X X X X X
Surgical parameters X
Urine output X X X X
Evaluation of complications X X X X X
Discharge criteria X X X
Laboratory values
Serum creatinine X X X
D day, W week
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overall score in the QoR-40 scale at post-operative day
1. A 10-point difference represents a minimal clinically
relevant difference in the QoR-40 scale [19–22]. The
QoR-40 score after laparoscopic donor nephrectomy is
not previously assessed. For other procedures, standard
deviation of QoR-40 scores varies between 12 and 23
points [15, 23–27] with one study investigating the
QoR-40 score after laparoscopic surgery [18]. Data from
this study indicate a standard deviation of 14 in patients
after laparoscopic hysterectomy. As the group of living
kidney donors is highly homogeneous, we do not expect
a higher variation in the quality of recovery as compared
to patients after laparoscopic hysterectomy. Therefore,
we used a standard deviation of 14 for the sample
size calculation. In total, 64 patients are needed for
the proposed trial.
Statistical analysis
The data analysis will be based on an intention-to-treat
approach. Since we stratify for gender and side of donor
nephrectomy, factorial analysis of variance (ANOVA)
with a custom design will be used for statistical analysis.
P values < 0.05 will be considered statistically significant.
Statistical analyses will be performed with SPSS 22.0
(SPSS Inc., Chicago, IL, USA). A P value of 0.05 is con-
sidered statistically significant.
Discussion
Our primary hypothesis is that the use of low pressure
pneumoperitoneum, facilitated by deep neuromuscular
block, improves the quality of recovery during the
early post-operative phase after laparoscopic donor
nephrectomy.
Low pressure pneumoperitoneum may compromise
visibility of the surgical field. In this trial, safety of low
pressure pneumoperitoneum is ensured by assessment
of the SRS before each important step and every 15 mi-
nutes during the dissection phase. In case of insufficient
progression or visibility, intra-abdominal pressure will
be increased step-wise to standard pressure if needed.
Martini et al. have compared the relationship between
level of neuromuscular block and SRS in laparoscopic
surgery [11]. In this trial normal pressure was used in all
patients and deep neuromuscular block was associated
with better surgical visibility. Staehr-Rye et al. recently
completed a trial comparing surgical space conditions in
either deep muscle relaxation or moderate block during
low-pressure laparoscopic cholecystectomy [28]. Opti-
mal surgical space conditions were observed in 7 of 25
patients allocated to deep neuromuscular block versus 1
of 23 patients allocated to moderate block.
The main strength of this study is that we investigate
the clinical benefit of the use of low pressure pneumo-
peritoneum in a complex laparoscopic procedure. Also,
this is the first study in which the effect of low pressure
pneumoperitoneum is investigated in combination with
deep neuromuscular block from a patients’ perspective.
As standard quality of life questionnaires are not de-
signed to measure quality of recovery of surgery, we use
the validated QoR-40 questionnaire. A systematic review
performed in 2012 has shown that the QoR-40 question-
naire is a suitable assessment of post-operative quality of
recovery in a range of clinical and research situations
[29]. One of the limitations is the fact that the surgeon
cannot be completely blinded. A flaccid abdominal wall
may indicate the use of low intra-abdominal pressure.
To assess the efficacy of our blinding procedure, the sur-
geon will be asked at the end of the procedure whether
low or standard pressure was used. Another important
limitation is that there is not a validated instrument
for measuring perioperative conditions. In the trial by
Martini et al., eight surgeons, specialized in laparoscopic
surgery, independently scored SRS in the videos [11]. An
average κ statistic of 0.50 was found, indicating moder-
ate agreement. Currently, a validation study of subjective
rating scales to assess surgical conditions in laparoscopic
surgery is being performed (NCT02079337).
If this study shows that low pressure pneumoperito-
neum in combination with deep neuromuscular block
improves the quality of recovery after laparoscopic
donor nephrectomy, these results may be translated to
other complex laparoscopic procedures (e.g. laparo-
scopic upper gastrointestinal and colonic surgery).
Trial status
Recruiting patients
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